CCR5 rs1799987: Understanding This Promoter Variant
The rs1799987 variant is a single nucleotide polymorphism located in the promoter region of the CCR5 gene. It is associated with variations in the expression levels of the CCR5 receptor on immune cells and has been studied for its potential role in susceptibility to inflammatory conditions.
What each genotype means
Standard promoter activity
You carry two copies of the common A allele in the CCR5 promoter region (historically referenced as -2459A or -59029A). Research indicates this genotype maintains typical transcriptional activity and normal baseline CCR5 chemokine expression. Preliminary studies have examined its relationship with immune modulation at the maternal-fetal interface and recurrent pregnancy loss, but evidence remains limited and findings across populations are mixed.
Carried by approximately 30% to 35% of individuals in European and Asian populations.
Intermediate promoter activity
You have inherited one standard A allele and one variant G allele at rs1799987. Functional assays suggest this heterozygous genotype provides intermediate CCR5 promoter activity compared to homozygous states. Some association studies have evaluated this marker for subtle shifts in early implantation dynamics and pregnancy outcomes, though definitive clinical evidence is lacking and overall risk is not established.
Carried by roughly 45% to 50% of individuals across European, Asian, and global cohorts.
Reduced promoter activity
You carry two copies of the minor G allele (also known in older literature as -2459G), which has been linked in laboratory studies to roughly 45% reduced promoter activity and lower CCR5 surface expression. Small reproductive cohort studies have explored whether this reduced expression influences local decidual leukocyte migration and early pregnancy maintenance, but clinical evidence remains limited and inconclusive. This genetic result does not diagnose any reproductive condition or predict specific pregnancy outcomes.
Found in approximately 18% to 22% of individuals across European and Asian populations.
What is rs1799987?
The variant rs1799987 is a single nucleotide polymorphism (SNP) situated in the promoter region of the CCR5 gene. In genetic databases, it is often identified by the substitution of an adenine (A) for a guanine (G) at a specific position, sometimes referred to in older literature as 59029 A/G. Because this variant sits in the promoter—the "on-off switch" area of the gene—it is hypothesized to influence how much of the CCR5 protein is produced by the cell. By altering the regulatory landscape of the gene, this SNP may change the density of CCR5 receptors on the surface of monocytes, which are a type of white blood cell critical to the immune system's inflammatory response. Understanding this variant requires looking at how these subtle changes in protein expression might influence the body's ability to regulate inflammation.
The Role of the CCR5 Gene
The CCR5 gene encodes the C-C chemokine receptor type 5, a protein that sits on the surface of various immune cells, including T cells and monocytes. This receptor acts as a docking station for chemokines, which are signaling molecules that guide immune cells to sites of infection or tissue damage. Beyond its role in normal immune surveillance, CCR5 is famously known as a co-receptor that some viruses, such as HIV-1, use to enter and infect human cells. Because of its central role in both immune cell trafficking and viral entry, variations in the CCR5 gene are frequently studied in the context of infectious diseases, autoimmune disorders, and inflammatory conditions. The expression level of this receptor is tightly controlled, and even minor genetic changes in the promoter region can theoretically shift the balance of immune activity.
Research and Associations
Research into rs1799987 has yielded mixed and sometimes conflicting results, reflecting the complexity of genetic associations. Some studies have identified a link between the G allele and an increased susceptibility to Löfgren’s syndrome, an acute form of sarcoidosis, suggesting that higher CCR5 expression on monocytes may contribute to the condition. Other research has explored its potential involvement in diabetic kidney disease and pregnancy outcomes, though evidence remains limited and inconsistent across different populations. For instance, while some studies suggest an association with renal damage in specific clinical contexts, others have found no significant correlation with type 2 diabetes or its complications. Because these findings are often specific to certain cohorts or ethnicities, it is important to view these associations as statistical observations rather than definitive predictors of health outcomes.
Population Frequency
The frequency of the rs1799987 variant varies significantly across different global populations. The G allele is relatively common in many groups, including European populations, where it appears at a frequency of approximately 43%. However, these frequencies are not uniform worldwide; studies have observed different allele distributions in African, South American, and other ancestral groups. This variability is a common feature of human genetic diversity, and it underscores why a genetic association found in one population may not necessarily replicate in another. Researchers often account for these ancestral differences when designing studies to ensure that findings are robust and not simply a result of population structure.
Interpreting Genetic Information
If you have received information about your rs1799987 genotype, it is important to understand that this variant is only one small piece of a much larger biological puzzle. Genetic associations with complex conditions like inflammatory diseases are rarely determined by a single SNP; they typically involve the interplay of many genes, environmental factors, and lifestyle choices. You cannot use this information to diagnose yourself or predict future health outcomes with certainty. If you are concerned about your risk for specific inflammatory conditions or have questions about how your genetics might influence your health, the best course of action is to consult with a qualified healthcare provider or a genetic counselor. They can help you interpret your results in the context of your personal and family medical history.
How common is this variant?
The G allele is common in many populations, with a frequency of approximately 43% in European cohorts, though this varies significantly by ancestry.
Frequently asked questions
Is rs1799987 a diagnostic test for sarcoidosis?
No, rs1799987 is not a diagnostic test. While some research has found a statistical association between this variant and susceptibility to Löfgren’s syndrome, it is not used in clinical practice to diagnose the condition.
Does this variant affect my risk of HIV?
The CCR5 gene is involved in HIV entry, but the primary genetic factor associated with HIV resistance is the CCR5-delta32 deletion, not the rs1799987 promoter SNP. You should not rely on this SNP to assess your risk of HIV infection.
Can I change my CCR5 expression levels?
CCR5 expression is regulated by complex biological processes. There is no evidence that you can or should attempt to alter your CCR5 expression levels based on your genotype.
Why do studies show different results for this SNP?
Genetic studies often show different results due to differences in study design, sample sizes, and the ancestral backgrounds of the participants. This is common in complex disease research and highlights the need for caution when interpreting single-variant associations.
Sources & further reading
Educational information only, last refreshed 10/26/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1799987?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29